Apple, J&J Launch New mHealth Study Targeting Wearables and AFib
Price: $ 93.00
4.8(640)
Apple and Johnson & Johnson are launching a new mHealth study aimed at testing the capabilities of the Apple Watch to detect and treat atrial fibrillation in seniors.
Wearable Technology: Innovation, Adherence, and Clinical Outcomes
Integration of novel monitoring devices with machine learning
Johnson & Johnson and Apple launch 'Heartline Study' to see if
Wearable health monitors not always reliable, study shows
Apple Watch: New Health Features for AFib and Medication Tracking
Full article: Lessons learned in the Apple Heart Study and
Smart wearable devices in cardiovascular care: where we are and
Rationale and design of a large-scale, app-based study to identify
Wearables and the medical revolution
Johnson & Johnson to start research with Apple to improve AFib
Sensors, Free Full-Text
J&J, Apple Seek To Improve AFib Outcomes